2 powerful stocks that could help your ASX share portfolio grow by leaps and bounds

Analysts see big returns ahead for these shares.

| More on:

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

In his most recent letter to shareholders, Warren Buffett wrote about how just a few big winners through the years have contributed materially to the success of Berkshire Hathaway (NYSE: BRK.B).

The Oracle of Omaha explained:

In 58 years of Berkshire management, most of my capital-allocation decisions have been no better than so-so. In some cases, also, bad moves by me have been rescued by very large doses of luck. (Remember our escapes from near-disasters at USAir and Salomon? I certainly do.) Our satisfactory results have been the product of about a dozen truly good decisions – that would be about one every five years – and a sometimes-forgotten advantage that favors long-term investors such as Berkshire.

The good news is that analysts believe there are a couple of powerful ASX shares that have been out of favour this year but could roar again over the coming years.

Which ASX shares could power your portfolio?

As Buffett mentioned above, investors may want to focus on buying quality companies with a long-term view.

Two ASX shares that analysts appear to believe could be quality long-term options are ResMed Inc. (ASX: RMD) and Treasury Wine Estates Ltd (ASX: TWE).

In respect to the former, ResMed is one of the world's leading sleep treatment companies. Its shares have fallen heavily this year due to concerns that weight loss drugs could limit its growth.

Goldman Sachs doesn't believe this will be the case and feels it still has a huge growth opportunity over the next few decades. It notes the following:

[O]n the threat from GLP-1s [weight loss drugs], RMD outlined its estimates of the global OSA TAM through 2050E and highlighted that, at current rates of market growth, RMD penetration would still be <10% by 2050E, even in its 'high pharma impact' scenario.

Goldman has a buy rating and a $25.78 price target on its shares.

What else?

Another ASX share that analysts expect to deliver powerful returns is Treasury Wine.

Morgans is bullish on the wine company following the acquisition of Paso Robles luxury wine business, DAOU Vineyards (DAOU) for US$900 million. It highlights that the "acquisition is in line with TWE's premiumisation and growth strategy and will strengthen a key gap in Treasury Americas (TA) portfolio."

Its analysts also note that "if TWE delivers on its investment case, there is material upside to our valuation." And that's despite the broker already seeing huge upside with its add rating and $14.15 price target.

Motley Fool contributor James Mickleboro has positions in ResMed and Treasury Wine Estates. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Berkshire Hathaway, Goldman Sachs Group, and ResMed. The Motley Fool Australia has positions in and has recommended ResMed. The Motley Fool Australia has recommended Berkshire Hathaway and Treasury Wine Estates. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Blue Chip Shares

A fit man flexes his muscles, indicating a positive share price movement on the ASX market
Blue Chip Shares

3 strong ASX 200 blue chip stocks to buy with $2,000 in December

These blue chips have been given the thumbs up from analysts.

Read more »

A share market analyst looks at his computer screen in front of him showing ASX share price movements
Blue Chip Shares

Analysts name 3 strong blue chip ASX 200 shares to buy in December

Let's see which blue chips are bring tipped as buys by analysts right now.

Read more »

three businessmen high five each other outside an office building with graphic images of graphs and metrics superimposed on the shot.
Blue Chip Shares

Buy these 3 high-quality ASX 200 blue chip shares in December

Analysts think these high-quality shares are buys right now. Let's see what they are saying.

Read more »

Two people comparing and analysing material.
Blue Chip Shares

Are Woodside or CBA shares a better buy?

Here’s how I’d compare these two major ASX blue chips.

Read more »

A group of young people lined up on a wall are happy looking at their laptops and devices as they invest in the latest trendy stock.
Blue Chip Shares

Why these ASX 200 blue chip shares could generate big returns

Brokers think these shares are could be dirt cheap at current levels.

Read more »

Man sits smiling at a computer showing graphs
Blue Chip Shares

3 ASX shares Australians can buy and hold for the next decade

Analysts think these high quality stocks could be in the buy zone right now.

Read more »

2 women looking at phone
Blue Chip Shares

3 high quality blue chip ASX 200 shares to buy in November

Here are a few blue chip shares that have been rated as buys this month by analysts.

Read more »

A businessman lights up the fifth star in a lineup, indicating positive share price for a top performer
Blue Chip Shares

2 of the highest-quality blue chip ASX 200 stocks money can buy

Analysts think these blue chips are top buys for investors right now. But why?

Read more »